ARCA Biopharma Inc ABIO:NASDAQ

Last Price$2.46NASDAQ Closing Price as of 4:00PM ET 6/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.07(2.77%)
Bid (Size)$2.46 (5)
Ask (Size)$2.49 (4)
Day Low / High$2.43 - 2.52
Volume74.1 K
  • Latest Stories
  • Commentary and Analysis
-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q1 Loss $-0.23
4:18PM ET 5/02/2022 MT Newswires

...

Arca Biopharma Board to Weigh Strategic Options for Company -- Shares Rise After-Hours
4:57PM ET 4/18/2022 MT Newswires

Arca Biopharma (ABIO) said Monday its board formed a special committee of directors to study potential strategic options to maximize stockholder value. ...

Correction: Sector Update: Health Care Stocks Finishing Near Friday Session Highs
10:51AM ET 4/04/2022 MT Newswires

(Corrects to show correct name of Sage's drug candidate in third paragraph.) Health care stocks added to their midday gains this afternoon, with the NYSE...

Sector Update: Health Care Stocks Finishing Near Friday Session Highs
4:05PM ET 4/01/2022 MT Newswires

Health care stocks added to their midday gains this afternoon, with the NYSE Health Care Index rising 0.6% while the SPDR Health Care Select Sector ETF...

Sector Update: Health Care Stocks Edging Higher in Friday Trading
1:48PM ET 4/01/2022 MT Newswires

Health care stocks were edging higher this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select Sector ETF (XLV) was up...

ARCA biopharma Says COVID-19 Treatment Study Fails to Meet Target; Shares Fall
10:37AM ET 4/01/2022 MT Newswires

ARCA biopharma (ABIO) said late Thursday its phase 2b trial evaluating the lower and higher doses of rNAPc2 for the potential treatment of hospitalized...

Top Premarket Decliners
8:11AM ET 4/01/2022 MT Newswires

Sellas Life Sciences (SLS) shares slumped 25% after the company priced a $25 million public offering. Nuvve (NVVE) shares tumbled 20% after the company...

ARCA biopharma Completes Enrollment in Phase 2b Trial of COVID-19 Treatment
9:48AM ET 12/02/2021 MT Newswires

ARCA biopharma (ABIO) said Thursday it has completed enrollment in the phase 2b clinical study evaluating rNAPc2 small recombinant protein as a potential...

-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q3 Loss $-0.33
4:21PM ET 11/02/2021 MT Newswires

...

Sector Update: Health Care Stocks Muted in Lead Up to Friday's Opening Bell
9:02AM ET 10/29/2021 MT Newswires

Health care stocks were muted ahead of the opening bell on Friday. The Health Care SPDR (XLV) was flat while the iShares NASDAQ Biotechnology Index (IBB)...